EFFICACY OF HAEMOPHILUS INFLUENZA TYPE B (B-Capsa 1) POLYSACCHARIDE VACCINE IN 87,541 CHILDREN

Pediatric Research - United States
doi 10.1203/00006450-198704010-00928
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Response to Immunization With Haemophilus Influenzae Type B Polysaccharide-Pertussis Vaccine and Risk of Haemophilus Meningitis in Children With the Km(1) Immunoglobulin Allotype.

Journal of Clinical Investigation
Medicine
1984English

Haemophilus Influenzae Type B Antigenuria in Children.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1979English

Preparation, Characterization, and Immunogenicity of Haemophilus Influenzae Type B Polysaccharide-Protein Conjugates

Journal of Experimental Medicine
MedicineAllergyImmunology
1980English

Safety and Immunogenicity of Haemophilus Influenzae Type B Conjugate Vaccine in Copd

Journal of Evolution of Medical and Dental Sciences
2016English

Enhanced Immunogenicity in Young Infants of a New Haemophilus Influenzae Type B(hib) Capsular Polysaccharide(prp)-Diphtheria Toxoid(d) Conjugate Vaccine

Pediatric Research
Child HealthPediatricsPerinatology
1984English

Quantitative Measurement of “Natural” and Immunization-Induced Haemophilus Influenzas Type B Capsular Polysaccharide Antibodies

Pediatric Research
Child HealthPediatricsPerinatology
1973English

Characteristic Features of Type B Haemophilus Influenzae-Caused Purulent Meningitis in Children

Perm Medical Journal
2018English

Antibody Responses to Haemophilus Influenzae Type B Conjugate Vaccine in Sickle Cell Disease.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1996English

Variability in the Functional Activity of Vaccine-Induced Antibody to Haemophilus Influenzae Type B

Pediatric Research
Child HealthPediatricsPerinatology
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy